|
US7041691B1
(en)
|
1999-06-30 |
2006-05-09 |
Amgen Inc. |
Compounds for the modulation of PPARγ activity
|
|
US20030171399A1
(en)
|
2000-06-28 |
2003-09-11 |
Tularik Inc. |
Quinolinyl and benzothiazolyl modulators
|
|
GB0031109D0
(en)
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7105551B2
(en)
|
2000-12-20 |
2006-09-12 |
Smithkline Beecham Corporation |
Thiazole derivatives for treating PPAR related disorders
|
|
HRP20040098B1
(en)
*
|
2001-08-13 |
2012-08-31 |
Janssen Pharmaceutica N.V. |
2,4,5-TRlSUBSTITUTED THIAZOLYL DERIVATIVES AND THEIR ANTIINFLAMMATORY ACTIVITY
|
|
US7259175B2
(en)
|
2002-02-25 |
2007-08-21 |
Eli Lilly And Company |
Peroxisome proliferator activated receptor modulators
|
|
GB0214139D0
(en)
|
2002-06-19 |
2002-07-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
CA2499380A1
(en)
|
2002-09-05 |
2004-03-18 |
Novo Nordisk A/S |
Novel vinyl carboxylic acid derivatives and their therapeutical use
|
|
JP2005035966A
(ja)
*
|
2002-09-06 |
2005-02-10 |
Takeda Chem Ind Ltd |
フランまたはチオフェン誘導体およびその医薬用途
|
|
US7553867B2
(en)
|
2002-09-06 |
2009-06-30 |
Takeda Pharmaceutical Company Limited |
Furan or thiophene derivative and medicinal use thereof
|
|
US20060052603A1
(en)
*
|
2002-09-19 |
2006-03-09 |
Jiasheng Guo |
Process for preparing substituted phenoxy-acetic acids from phenols
|
|
KR20050061562A
(ko)
|
2002-10-28 |
2005-06-22 |
노보 노르디스크 에이/에스 |
신규 화합물, 그들의 제제 및 사용
|
|
US20050080115A1
(en)
|
2002-10-28 |
2005-04-14 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
|
US7129268B2
(en)
|
2002-10-28 |
2006-10-31 |
Novo Nordisk A/S |
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
|
|
DE60332860D1
(de)
|
2002-10-28 |
2010-07-15 |
High Point Pharmaceuticals Llc |
Neue verbindungen, die sich f r die behandlung von durch ppar vermittelten krankheiten eignen
|
|
DE10308355A1
(de)
|
2003-02-27 |
2004-12-23 |
Aventis Pharma Deutschland Gmbh |
Aryl-cycloalkyl substituierte Alkansäurederivate, Verfahren zu ihrer Herstellung und ihre Anwendung als Arzneimittel
|
|
US7223761B2
(en)
|
2003-10-03 |
2007-05-29 |
Amgen Inc. |
Salts and polymorphs of a potent antidiabetic compound
|
|
WO2005105736A1
(en)
|
2004-05-05 |
2005-11-10 |
Novo Nordisk A/S |
Novel compounds, their preparation and use
|
|
ES2352085T3
(es)
|
2004-05-05 |
2011-02-15 |
High Point Pharmaceuticals, Llc |
Nuevos compuestos, su preparación y uso.
|
|
RU2007148439A
(ru)
*
|
2005-05-25 |
2009-06-27 |
Ниппон Кемифар Ко., Лтд. (JP) |
Активатор для рецептора, активируемого пролифератором пероксисом
|
|
ES2372617T3
(es)
|
2005-06-30 |
2012-01-24 |
High Point Pharmaceuticals, Llc |
Ácidos fenoxiacéticos como activadores de ppar-delta.
|
|
EA201101085A1
(ru)
|
2005-12-22 |
2012-05-30 |
ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи |
Феноксиуксусные кислоты в качестве активаторов ppar дельта
|
|
JP2009132620A
(ja)
*
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
|
EP1999098A2
(en)
|
2006-03-09 |
2008-12-10 |
High Point Pharmaceuticals, LLC |
Compounds that modulate ppar activity, their preparation and use
|
|
EP2014652B1
(en)
|
2006-04-18 |
2014-08-06 |
Nippon Chemiphar Co., Ltd. |
Activating agent for peroxisome proliferator activated receptor
|
|
MEP8509A
(en)
|
2006-09-07 |
2011-12-20 |
|
Combination treatment for diabetes mellitus
|
|
FR2910893A1
(fr)
*
|
2006-12-29 |
2008-07-04 |
Genfit Sa |
Derives de (phenylthiazolyl)-phenyl-propan-1-one et de (phenyloxazolyl)-phenyl-propan-1-one substitues, preparations et utilisations.
|
|
PT2152663E
(pt)
|
2007-06-04 |
2014-06-03 |
Univ Ben Gurion |
Compostos de triarilo e composições que compreendem os mesmos
|
|
MX2010011252A
(es)
|
2008-04-15 |
2010-11-30 |
Nippon Chemiphar Co |
Activador para el receptor activado por el proliferador de peroxisoma.
|
|
US20120094959A1
(en)
|
2010-10-19 |
2012-04-19 |
Bonnie Blazer-Yost |
Treatment of cystic diseases
|
|
WO2012122368A1
(en)
*
|
2011-03-08 |
2012-09-13 |
The Regents Of The University Of California |
Deoxycytidine kinase binding compounds
|
|
WO2015035171A1
(en)
|
2013-09-09 |
2015-03-12 |
High Point Pharmaceuticals, Llc |
Use of a ppar-delta agonist for treating muscle atrophy
|
|
EP3065723B1
(en)
|
2013-11-05 |
2020-09-23 |
Ben Gurion University of the Negev Research and Development Authority |
Compounds for the treatment of diabetes and disease complications arising from same
|
|
AU2020405068A1
(en)
|
2019-12-18 |
2022-07-07 |
Stinginn Llc |
Substituted 1,2, 4-triazoles and methods of use
|
|
PE20231656A1
(es)
|
2020-11-02 |
2023-10-17 |
Trethera Corp |
Formas cristalinas de un inhibidor de cinasa de desoxicitidina y sus usos
|
|
CA3217437A1
(en)
*
|
2021-05-19 |
2022-11-24 |
Glen Barber |
Small molecular inhibitors of sting signaling compositions and methods of use
|
|
WO2023147309A1
(en)
|
2022-01-25 |
2023-08-03 |
Reneo Pharmaceuticals, Inc. |
Use of ppar-delta agonists in the treatment of disease
|